Skip Prichard

JULY 22, 2019

Innovation Capital. And one of the most overlooked reasons for entrepreneurial failure is innovation capital. That’s why I enjoyed talking with Jeff Dyer who, along with Nathan Furr and Curtis Lefrandt, wrote a new book, Innovation Capital: How to Compete and Win Like the World’s Innovative Leaders. Satya Nadella.

Innovation 80

Innovation Social Capital Reputation How To 80

Harvard Business Review

MARCH 11, 2014

That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And biotechnology and medical devices are among the leading areas for venture capital funding. In all of these settings, physicians and patients are happy.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

OCTOBER 26, 2011

Between 2008 and 2010, over 25 US-based, cleantech-focused venture capital and private equity funds raised over $300 million in committed capital each, amounting to over $35 billion of capital committed for clean energy startups (here's an example ). Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MAY 2, 2011

In 2010, China overtook Japan to become the world's second largest R&D spender (in purchasing power parity terms) after the U.S. Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese.

Globalization 13

Globalization Marketing Venture Capitalist Biotechnology 13

Harvard Business Review

FEBRUARY 24, 2017

We analyzed required public disclosure information about congresspeople’s stock holdings as compiled by the Center for Responsive Politics , a nonpartisan nonprofit, in combination with a sample of S&P 500 performance data from 2005 to 2010. Not only did his wife invest between $610,000 and $1.5

Conflict of Interest 8

Conflict of Interest Committee Collins Politics 8